Literature DB >> 7744694

Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas.

M Kai1, H Arakawa, Y Sugimoto, Y Murata, M Ogawa, Y Nakamura.   

Abstract

We examined a candidate tumor suppressor gene on chromosome 9p21, MTS1/CDK4I (multiple tumor suppressor 1/cyclin-dependent kinase 4 inhibitor), which has been found to be mutated frequently in cell lines derived from bladder carcinomas, for somatic mutations in 39 primary bladder cancers by means of SSCP (single-stranded conformational polymorphism) and DNA sequencing. Mutations were detected in two of these carcinomas; one was a 61-base deletion and the other a 1-base deletion. In both cases the homologous allele was missing, indicating that "two-hit" mutation of the MTS1 gene had taken place in these tumors. The results indicated that inactivation of the MTS1 gene is likely to be a contributing factor in some, but not the majority of, bladder cancers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744694      PMCID: PMC5920817          DOI: 10.1111/j.1349-7006.1995.tb03047.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

1.  An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A.

Authors:  S C Kogan; M Doherty; J Gitschier
Journal:  N Engl J Med       Date:  1987-10-15       Impact factor: 91.245

2.  Germline p16 mutations in familial melanoma.

Authors:  C J Hussussian; J P Struewing; A M Goldstein; P A Higgins; D S Ally; M D Sheahan; W H Clark; M A Tucker; N C Dracopoli
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

3.  Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.

Authors:  I Orlow; P Lianes; L Lacombe; G Dalbagni; V E Reuter; C Cordon-Cardo
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

4.  Role of chromosome 9 in human bladder cancer.

Authors:  N Miyao; Y C Tsai; S P Lerner; A F Olumi; C H Spruck; M Gonzalez-Zulueta; P W Nichols; D G Skinner; P A Jones
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

5.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.

Authors:  T Nobori; K Miura; D J Wu; A Lois; K Takabayashi; D A Carson
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

6.  Rates of p16 (MTS1) mutations in primary tumors with 9p loss.

Authors:  P Cairns; L Mao; A Merlo; D J Lee; D Schwab; Y Eby; K Tokino; P van der Riet; J E Blaugrund; D Sidransky
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

7.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

Authors:  T Mori; K Miura; T Aoki; T Nishihira; S Mori; Y Nakamura
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

8.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.

Authors:  P Cairns; K Tokino; Y Eby; D Sidransky
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

10.  Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas.

Authors:  N Hayashi; Y Sugimoto; E Tsuchiya; M Ogawa; Y Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

View more
  3 in total

1.  Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.

Authors:  F Kimura; A R Florl; H H Seifert; J Louhelainen; S Maas; M A Knowles; W A Schulz
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

2.  Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines.

Authors:  T Sørlie; G Martel-Planche; P Hainaut; J Lewalter; R Holm; A L Børresen-Dale; R Montesano
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

3.  Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer.

Authors:  A Komiya; H Suzuki; S Aida; R Yatani; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1995-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.